FDA.reportPublic FDA data

Application 065031

Type
ANDA
Sponsor
HOSPIRA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BLEOMYCIN SULFATEBLEOMYCIN SULFATEINJECTABLE;INJECTIONEQ 15 UNITS BASE/VIALNoNo
002BLEOMYCIN SULFATEBLEOMYCIN SULFATEINJECTABLE;INJECTIONEQ 30 UNITS BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0409-0323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
0409-0332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-323BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-332BleomycinBLEOMYCINHospira, Inc.ANDACurrent
61703-332BleomycinBLEOMYCINHospira, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
30629ORIG2000-03-10